These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25339884)

  • 1. Two Alzheimer's disease risk genes increase entorhinal cortex volume in young adults.
    DiBattista AM; Stevens BW; Rebeck GW; Green AE
    Front Hum Neurosci; 2014; 8():779. PubMed ID: 25339884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
    Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults.
    Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu TT; Helm JL; Wierenga CE
    Neuroimage; 2019 Nov; 202():116162. PubMed ID: 31493534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's disease.
    Chen J; Shu H; Wang Z; Liu D; Shi Y; Xu L; Zhang Z
    Oncotarget; 2016 Sep; 7(37):58789-58801. PubMed ID: 27542235
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Coughlan G; Larsen R; Kim M; White D; Gillings R; Irvine M; Scholey A; Cohen N; Legido-Quigley C; Hornberger M; Minihane AM
    Brain Commun; 2021; 3(2):fcab085. PubMed ID: 34007965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging.
    Gupta VB; Doecke JD; Hone E; Pedrini S; Laws SM; Thambisetty M; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Macaulay SL; Rembach A; Rainey-Smith SR; Martins RN;
    Alzheimers Dement (Amst); 2016; 3():18-26. PubMed ID: 27239546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of APOE, cerebral blood flow, and cortical thickness in the entorhinal cortex predicts memory decline.
    Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu T; Helm JL; Wierenga CE
    Brain Imaging Behav; 2020 Apr; 14(2):369-382. PubMed ID: 32048144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.
    Cacciaglia R; Molinuevo JL; Falcón C; Brugulat-Serrat A; Sánchez-Benavides G; Gramunt N; Esteller M; Morán S; Minguillón C; Fauria K; Gispert JD;
    Alzheimers Dement; 2018 Jul; 14(7):902-912. PubMed ID: 29605385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease.
    Donix M; Burggren AC; Scharf M; Marschner K; Suthana NA; Siddarth P; Krupa AK; Jones M; Martin-Harris L; Ercoli LM; Miller KJ; Werner A; von Kummer R; Sauer C; Small GW; Holthoff VA; Bookheimer SY
    Psychiatry Res; 2013 Dec; 214(3):212-20. PubMed ID: 24080518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
    J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein ε4 is associated with lower brain volume in cognitively normal Chinese but not white older adults.
    Yokoyama JS; Lee AK; Takada LT; Busovaca E; Bonham LW; Chao SZ; Tse M; He J; Schwarz CG; Carmichael OT; Matthews BR; Karydas A; Weiner MW; Coppola G; DeCarli CS; Miller BL; Rosen HJ
    PLoS One; 2015; 10(3):e0118338. PubMed ID: 25738563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
    Konishi K; Joober R; Poirier J; MacDonald K; Chakravarty M; Patel R; Breitner J; Bohbot VD
    J Alzheimers Dis; 2018; 61(4):1493-1507. PubMed ID: 29278888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
    Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
    Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Effects of the Apolipoprotein E ε4 Allele on Episodic Memory, Task Switching and Gray Matter Volume in Healthy Young Adults.
    Nao J; Sun H; Wang Q; Ma S; Zhang S; Dong X; Ma Y; Wang X; Zheng D
    Front Hum Neurosci; 2017; 11():346. PubMed ID: 28706481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice.
    Montoliu-Gaya L; Güell-Bosch J; Esquerda-Canals G; Roda AR; Serra-Mir G; Lope-Piedrafita S; Sánchez-Quesada JL; Villegas S
    Biochem Pharmacol; 2018 Sep; 155():380-392. PubMed ID: 30026023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.
    Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W
    J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.
    Malek-Ahmadi M; Beach T; Obradov A; Sue L; Belden C; Davis K; Walker DG; Lue L; Adem A; Sabbagh MN
    Curr Alzheimer Res; 2013 Jul; 10(6):654-9. PubMed ID: 23627755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE-ε4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals.
    Cacciaglia R; Molinuevo JL; Falcón C; Sánchez-Benavides G; Gramunt N; Brugulat-Serrat A; Esteller M; Morán S; Fauria K; Gispert JD;
    Neuroimage Clin; 2019; 23():101818. PubMed ID: 30991302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familiarity deficits in cognitively normal aging individuals with
    Schoemaker D; Poirier J; Collins DL; Gauthier S; Pruessner JC
    Alzheimers Dement (Amst); 2017; 9():21-24. PubMed ID: 28761928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.